Albizia lebbeck (Linn.) Willd.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Mimosaceae. |
| Habitat | All over India, from the plains up to 900 m in the Himalayas; also in the Andamans. |
| English | Siris tree, East Indian walnut. |
| Ayurvedic | Shirisha, Bhandi, Bhandila, Shitapushpa, Mridupushpa, Kapitana (bark—dusty black). |
| Unani | Siras. |
| Siddha / Tamil | Vaagei. |
| Action | Antiseptic, antibacterial, antiallergic, antidermatosis, antidysenteric. Bark—used in bronchitis; bark and seeds in piles; root in hemicrania; flowers in cough, bronchitis, tropical pulmonary eosinophilia, and asthma. Pod— antiprotozoal. |
| Dosage | Stembark—3–6 g powder. 20–50 g for decoction. (API Vol. III.) |
| Taxonomic Cohort | Genus Albizia (3 documented species); Family Mimosaceae (24 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Albizia lebbeck (taxonomically cited with authority (Linn.) Willd.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Mimosaceae (primary family classification: Mimosaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: All over India, from the plains up to 900 m in the Himalayas; also in the Andamans.
Across classical and vernacular Indian systems of medicine, Albizia lebbeck is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Siris tree, East Indian walnut; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Shirisha, Bhandi, Bhandila, Shitapushpa, Mridupushpa, Kapitana (bark—dusty black); in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Siras; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Vaagei. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Albizia lebbeck are: Antiseptic, antibacterial, antiallergic, antidermatosis, antidysenteric. Bark—used in bronchitis; bark and seeds in piles; root in hemicrania; flowers in cough, bronchitis, tropical pulmonary eosinophilia, and asthma. Pod— antiprotozoal. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Albizia lebbeck establish the following evidence base: Along with other therapeutic applications, The Ayurvedic Pharmacopoeia of India indicates the use of stembark in rhinitis, sinusitis and migraine. Analysis of the plant revealed the presence of flavonoids, triterpenoids and triterpenoid saponins; oleanolic acid, albigenic acid, albigenin and acacic acid. The bark contains 7–11% condensed tannin; also d-catechin and d-leucocyanidin. Aqueous extract of the bark decreased histamine-induced bronchospasm in guinea pigs. Alcoholic extract of stembark contains cardenolide glycosides of digitoxin nature. It showed antidermatophytic activity. Anthraquinone glycosides and its aglycone exhibited antibacterial activity. A saponin from seeds exhibited spermicidal activity in animals. EtOH (50%) extract of pods was found to be spermicidal against rat and human spermatozoa at 2% concentration. The therapeutic properties of Albizia julibrissin Durazz, Pink Siris, found in the outer Himalayas from the Indus eastwards to Sikkim, are the same as those of A. lebbeck.
In specialized pharmacognostic classifications, Albizia lebbeck is also listed among standardized commercial herbal extracts used in India with defined quantitative phytochemical markers; and represented by authenticated macro-photographic crude drug specimens in institutional pharmacognostic collections.

Figure 1: Authenticated crude herb specimen — Albizia lebbeck bark.

Botanical Reference 1: Albizia lebbeck — Botanical specimen

Botanical Reference 2: Albizia lebbeck — Botanical specimen

Botanical Reference 3: Albizia lebbeck — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Albizia comprises 3 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Albizia amara (Action: Leaf and flower—antiinflammatory, used for boils and ulcers. Leaf—used for…); Albizia procera (Action: Bark—a decoction is given in rheumatism and haemorrhage). Comparing Albizia lebbeck alongside its congeners in genus Albizia highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Mimosaceae encompasses 24 documented medicinal species (1.32% of the 1,814-species flora). Other representative medicinal members of Mimosaceae include: Acacia arabica indica (Babbuula), Acacia canescens (Aadaari), Acacia catechu (Khadira), Acacia chundra (Khadira), Dichrostachys cinerea (Virataru). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 2: Quantitative documentation profile across all 24 medicinal species of family Mimosaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
For clinical and traditional dispensing, the standardized posology and crude herb dosage for Albizia lebbeck are prescribed as follows: Stembark—3–6 g powder. 20–50 g for decoction. (API Vol. III.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Albizia lebbeck integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.